Abstract
Purpose of Review
The purpose of this review is to provide an update on pediatric intracranial hypertension.
Recent Findings
The annual pediatric incidence is estimated at 0.63 per 100,000 in the USA and 0.71 per 100,000 in Britain. The Idiopathic Intracranial Hypertension Treatment Trial found improvement in visual fields, optical coherence tomography, Frisen grade, and quality of life with acetazolamide compared to placebo in adult patients, and these findings have been translated to the pediatric population.
Summary
Pediatric intracranial hypertension is a disorder that if left untreated can lead to poor quality of life and morbidity. There are no current treatment studies in pediatrics, but adult data suggests acetazolamide remains an acceptable first-line medication.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Quincke H. Uber Meningitis serosa and verwandte Zustande. Dtsch Z Nervenheilkd. 1897;9:149–68. (Atricle in German).
Nonne M. Ueber Falle vom Symptomkomplex “tumor cerebri” mit Ausgang in Heilung. Dtsch Z Nervenheilkd. 1904;27(3–4):169–216. https://doi.org/10.1007/BF01667111.
Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39(8):461–74. https://doi.org/10.1001/archneur.1982.00510200003001.
Wall M, Hart WM Jr, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 1983;96(5):654–69. https://doi.org/10.1016/S0002-9394(14)73425-7.
Foley J. Benign forms of intracranial hypertension; toxic and otitic hydrocephalus. Brain. 1955;78(1):1–41. https://doi.org/10.1093/brain/78.1.1.
Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32(2):363–96. https://doi.org/10.1016/j.ncl.2014.01.001.
• Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65. Most recent adult and pediatric revision attempt. https://doi.org/10.1212/WNL.0b013e3182a55f17.
• Aylward SC. Pediatric idiopathic intracranial hypertension: a need for clarification. Pediatr Neurol. 2013;49(5):303–4. Pediatric intracranial hypertension criteria. https://doi.org/10.1016/j.pediatrneurol.2013.05.019.
Sodhi M, Sheldon CA, Carleton B, Etminan M. Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: nested case-control study. Neurology. 2017;89(8):792–5. https://doi.org/10.1212/WNL.0000000000004247.
Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106(4):492–513. https://doi.org/10.1097/00000658-193710000-00002.
Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985;5(1):55–6.
Maralani PJ, Hassanlou M, Torres C, Chakraborty S, Kingstone M, Patel V, et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol. 2012;67(7):656–63. https://doi.org/10.1016/j.crad.2011.12.002.
Gorkem SB, Doganay S, Canpolat M, Koc G, Dogan MS, Per H, et al. MR imaging findings in children with pseudotumor cerebri and comparison with healthy controls. Child’s Nerv Syst. 2015;31(3):373–80. https://doi.org/10.1007/s00381-014-2579-0.
• Inger HE, Rogers DL, McGregor ML, Aylward SC, Reem RE. Diagnostic criteria in pediatric intracranial hypertension. J AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus. 2017;21(6):492-5 e2. https://doi.org/10.1016/j.jaapos.2017.08.003 Application of past patients with modern proposed criteria.
• Gerstl L, Schoppe N, Albers L, Ertl-Wagner B, Alperin N, Ehrt O, et al. Pediatric idiopathic intracranial hypertension—is the fixed threshold value of elevated LP opening pressure set too high? Eur J Paediatr Neurol. 2017;21(6):833–41. Application of past patients with modern proposed criteria. https://doi.org/10.1016/j.ejpn.2017.08.002.
Tschudy MM, Arcara KM, Johns Hopkins Hospital. Children’s Medical and Surgical Center. The Harriet Lane handbook: a manual for pediatric house officers. 19th ed. Philadelphia: Mosby Elsevier; 2012. xvi, 1132 p., 10 p. of plates p
Swaiman KF. Swaiman’s pediatric neurology: principles and practice. 5th ed. Elsevier Saunders: Edinburgh; 2012.
Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52(6):597–617. https://doi.org/10.1016/j.survophthal.2007.08.018.
Avery RA, Shah SS, Licht DJ, Seiden JA, Huh JW, Boswinkel J, et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010;363(9):891–3. https://doi.org/10.1056/NEJMc1004957.
Lee MW, Vedanarayanan VV. Cerebrospinal fluid opening pressure in children: experience in a controlled setting. Pediatr Neurol. 2011;45(4):238–40. https://doi.org/10.1016/j.pediatrneurol.2011.07.002.
Williams BJ, Skinner HJ, Maria BL. Increased intracranial pressure in a case of pediatric multiple sclerosis. J Child Neurol. 2008;23(6):699–702. https://doi.org/10.1177/0883073807313040.
Narula S, Liu GT, Avery RA, Banwell B, Waldman AT. Elevated cerebrospinal fluid opening pressure in a pediatric demyelinating disease cohort. Pediatr Neurol. 2015;52(4):446–9. https://doi.org/10.1016/j.pediatrneurol.2015.01.002.
Morgan-Followell B, Aylward SC. Comparison of cerebrospinal fluid opening pressure in children with demyelinating disease to children with primary intracranial hypertension. J Child Neurol. 2017;32(4):366–70. https://doi.org/10.1177/0883073816681936.
7.1.1 Headache attributed to idiopathic intracranial hypertension (IIH). https://www.ichd-3.org/7-headache-attributed-to-non-vascular-intracranial-disorder/7-1-headache-attributed-to-increased-cerebrospinal-fluid-pressure/7-1-1-headache-attributed-to-idiopathic-intracranial-hypertension-iih/.
Avery RA, Mistry RD, Shah SS, Boswinkel J, Huh JW, Ruppe MD, et al. Patient position during lumbar puncture has no meaningful effect on cerebrospinal fluid opening pressure in children. J Child Neurol. 2010;25(5):616–9. https://doi.org/10.1177/0883073809359198.
Lim MJ, Lin JP. The effects of carbon dioxide on measuring cerebral spinal fluid pressure. Child's Nerv Syst. 2009;25(7):783–4. https://doi.org/10.1007/s00381-009-0902-y.
•• Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875–7. First report of pediatric incidence in the United States. https://doi.org/10.1001/archneur.1988.00520320065016.
Gillson N, Jones C, Reem RE, Rogers DL, Zumberge N, Aylward SC. Incidence and demographics of pediatric intracranial hypertension. Pediatr Neurol. 2017;73:42–7. https://doi.org/10.1016/j.pediatrneurol.2017.04.021.
Tibussek D, Distelmaier F, von Kries R, Mayatepek E. Pseudotumor cerebri in childhood and adolescence—results of a Germany-wide ESPED-survey. Klin Padiatr. 2013;225(2):81–5. https://doi.org/10.1055/s-0033-1333757.
Dessardo NS, Dessardo S, Sasso A, Sarunic AV, Dezulovic MS. Pediatric idiopathic intracranial hypertension: clinical and demographic features. Coll Antropol. 2010;34(Suppl 2):217–21.
Matthews YY, Dean F, Lim MJ, McLachlan K, Rigby AS, Solanki GA, et al. Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child. 2017;102(8):715–21. https://doi.org/10.1136/archdischild-2016-312238.
Tibussek D, Schneider DT, Vandemeulebroecke N, Turowski B, Messing-Juenger M, Willems PH, et al. Clinical spectrum of the pseudotumor cerebri complex in children. Child’s Nerv Syst. 2010;26(3):313–21. https://doi.org/10.1007/s00381-009-1018-0.
Bursztyn LL, Sharan S, Walsh L, LaRoche GR, Robitaille J, De Becker I. Has rising pediatric obesity increased the incidence of idiopathic intracranial hypertension in children? Can J Ophthalmol. 2014;49(1):87–91. https://doi.org/10.1016/j.jcjo.2013.09.015.
Beri S, Chandratre S, Chow G. Familial idiopathic intracranial hypertension with variable phenotype. Eur J Paediatr Neurol. 2011;15(1):81–3. https://doi.org/10.1016/j.ejpn.2010.02.005.
Corbett JJ. The first Jacobson Lecture. Familial idiopathic intracranial hypertension. J Neuroophthalmol. 2008;28(4):337–47. https://doi.org/10.1097/WNO.0b013e31818f12a2.
Polemikos M, Heissler HE, Hermann EJ, Krauss JK. Idiopathic intracranial hypertension in monozygotic female twins: intracranial pressure dynamics and treatment outcome. World Neurosurg. 2017;101:814 e11–4. https://doi.org/10.1016/j.wneu.2017.03.004.
•• Aylward SC, Aronowitz C, Roach ES. Intracranial hypertension without papilledema in children. J Child Neurol. 2016;31(2):177–83. IIHTT outcomes in the first large-scale adult trial. https://doi.org/10.1177/0883073815587029.
Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57(8):1303–10. https://doi.org/10.1111/head.13144.
Aylward SC, Aronowitz C, Reem R, Rogers D, Roach ES. Intracranial hypertension without headache in children. J Child Neurol. 2015;30(6):703–6. https://doi.org/10.1177/0883073814540522.
Aylward SC, Waslo CS, Au JN, Tanne E. Manifestations of pediatric intracranial hypertension from the intracranial hypertension registry. Pediatr Neurol. 2016;61:76–82. https://doi.org/10.1016/j.pediatrneurol.2016.04.007.
Brainard L, Chen DA, Aziz KM, Hillman TA. Association of benign intracranial hypertension and spontaneous encephalocele with cerebrospinal fluid leak. Otol Neurotol. 2012;33(9):1621–4. https://doi.org/10.1097/MAO.0b013e318271c312.
Rosenfeld E, Dotan G, Kimchi TJ, Kesler A. Spontaneous cerebrospinal fluid otorrhea and rhinorrhea in idiopathic intracranial hypertension patients. J Neuroophthalmol. 2013;33(2):113–6. https://doi.org/10.1097/WNO.0b013e18274b870.
Kunte H, Schmidt F, Kronenberg G, Hoffmann J, Schmidt C, Harms L, et al. Olfactory dysfunction in patients with idiopathic intracranial hypertension. Neurology. 2013;81(4):379–82. https://doi.org/10.1212/WNL.0b013e31829c5c9d.
Bershad EM, Urfy MZ, Calvillo E, Tang R, Cajavilca C, Lee AG, et al. Marked olfactory impairment in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2014;85(9):959–64. https://doi.org/10.1136/jnnp-2013-307232.
Kharkar S, Hernandez R, Batra S, Metellus P, Hillis A, Williams MA, et al. Cognitive impairment in patients with pseudotumor cerebri syndrome. Behav Neurol. 2011;24(2):143–8. https://doi.org/10.1155/2011/630475.
Yri HM, Fagerlund B, Forchhammer HB, Jensen RH. Cognitive function in idiopathic intracranial hypertension: a prospective case-control study. BMJ Open. 2014;4(4):e004376. https://doi.org/10.1136/bmjopen-2013-004376.
•• Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(1):26–30. Papilledema grading scale. https://doi.org/10.1097/WNO.0000000000000199.
•• Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45(1):13–8. Comparison of pediatric imaging in papilledema vs pseudopapilledema. https://doi.org/10.1136/jnnp.45.1.13.
Chang MY, Velez FG, Demer JL, Bonelli L, Quiros PA, Arnold AC, et al. Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus pseudopapilledema. Ophthalmology. 2017;124(12):1839–48. https://doi.org/10.1016/j.ophtha.2017.06.016.
Atta HR. Imaging of the optic nerve with standardised echography. Eye (Lond). 1988;2(Pt 4):358–66. https://doi.org/10.1038/eye.1988.66.
Irazuzta JE, Brown ME, Akhtar J. Bedside optic nerve sheath diameter assessment in the identification of increased intracranial pressure in suspected idiopathic intracranial hypertension. Pediatr Neurol. 2016;54:35–8. https://doi.org/10.1016/j.pediatrneurol.2015.08.009.
Carter SB, Pistilli M, Livingston KG, Gold DR, Volpe NJ, Shindler KS, et al. The role of orbital ultrasonography in distinguishing papilledema from pseudopapilledema. Eye (Lond). 2014;28(12):1425–30. https://doi.org/10.1038/eye.2014.210.
Kurz-Levin MM, Landau KA. Comparison of imaging techniques for diagnosing drusen of the optic nerve head. Arch Ophthalmol. 1999;117(8):1045–9. https://doi.org/10.1001/archopht.117.8.1045.
Kulkarni KM, Pasol J, Rosa PR, Lam BL. Differentiating mild papilledema and buried optic nerve head drusen using spectral domain optical coherence tomography. Ophthalmology. 2014;121(4):959–63. https://doi.org/10.1016/j.ophtha.2013.10.036.
El-Dairi MA, Holgado S, O'Donnell T, Buckley EG, Asrani S, Freedman SF. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS. 2007;11(6):564–70. https://doi.org/10.1016/j.jaapos.2007.06.018.
Martinez MR, Ophir A. Optical coherence tomography as an adjunctive tool for diagnosing papilledema in young patients. J Pediatr Ophthalmol Strabismus. 2011;48(3):174–81. https://doi.org/10.3928/01913913-20100719-05.
Lee YA, Tomsak RL, Sadikovic Z, Bahl R, Sivaswamy L. Use of ocular coherence tomography in children with idiopathic intracranial hypertension—a single-center experience. Pediatr Neurol. 2016;58:101–6 e1. https://doi.org/10.1016/j.pediatrneurol.2015.10.022.
Pineles SL, Arnold AC. Fluorescein angiographic identification of optic disc drusen with and without optic disc edema. J Neuroophthalmol. 2012;32(1):17–22. https://doi.org/10.1097/WNO.0b013e31823010b8.
Fraser JA, Leung AE. Reversibility of MRI features of pseudotumor cerebri syndrome. J Can Sci Neurol. 2014;41(4):530–2. https://doi.org/10.1017/S0317167100018643.
Hartmann AJ, Soares BP, Bruce BB, Saindane AM, Newman NJ, Biousse V, et al. Imaging features of idiopathic intracranial hypertension in children. J Child Neurol. 2017;32(1):120–6. https://doi.org/10.1177/0883073816671855.
Horev A, Hallevy H, Plakht Y, Shorer Z, Wirguin I, Shelef I. Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: a prospective MRI study. J Neuroimaging. 2013;23(3):375–8. https://doi.org/10.1111/j.1552-6569.2012.00732.x.
Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain. 1974;97(2):301–12.
McLaren SH, Monuteaux MC, Delaney AC, Landschaft A, Kimia AA. How much cerebrospinal fluid should we remove prior to measuring a closing pressure? J Child Neurol. 2017;32(4):356–9. https://doi.org/10.1177/0883073816681352.
Hatfield MK, Handrich SJ, Willis JA, Beres RA, Zaleski GX. Blood patch rates after lumbar puncture with Whitacre versus Quincke 22- and 20-gauge spinal needles. AJR Am J Roentgenol. 2008;190(6):1686–9. https://doi.org/10.2214/AJR.07.3351.
Engedal TS, Ording H, Vilholm OJ. Changing the needle for lumbar punctures: results from a prospective study. Clin Neurol Neurosurg. 2015;130:74–9. https://doi.org/10.1016/j.clineuro.2014.12.020.
Castrillo A, Tabernero C, Garcia-Olmos LM, Gil C, Gutierrez R, Zamora MI, et al. Postdural puncture headache: impact of needle type, a randomized trial. Spine J. 2015;15(7):1571–6. https://doi.org/10.1016/j.spinee.2015.03.009.
Bellamkonda VR, Wright TC, Lohse CM, Keaveny VR, Funk EC, Olson MD, et al. Effect of spinal needle characteristics on measurement of spinal canal opening pressure. Am J Emerg Med. 2017;35(5):769–72. https://doi.org/10.1016/j.ajem.2017.01.047.
Berezovsky DE, Bruce BB, Vasseneix C, Peragallo JH, Newman NJ, Biousse V. Cerebrospinal fluid total protein in idiopathic intracranial hypertension. J Neurol Sci. 2017;381:226–9. https://doi.org/10.1016/j.jns.2017.08.3264.
Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–7. https://doi.org/10.1111/j.1600-0404.2007.00905.x.
Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology. 2011;76(18):1564–7. https://doi.org/10.1212/WNL.0b013e3182190f51.
Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341(jul07 2):c2701. https://doi.org/10.1136/bmj.c2701.
Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105(12):2313–7. https://doi.org/10.1016/S0161-6420(98)91234-9.
Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107(10):1907–12. https://doi.org/10.1016/S0161-6420(00)00340-7.
Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118(2):412–4. https://doi.org/10.1016/j.ophtha.2010.06.025.
Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993;100(5):683–90. https://doi.org/10.1016/S0161-6420(93)31588-5.
Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O'Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts—case series and literature review. Br J Neurosurg. 2011;25(1):94–9. https://doi.org/10.3109/02688697.2010.544781.
Liu A, Elder BD, Sankey EW, Goodwin CR, Jusue-Torres I, Rigamonti D. Are shunt series and shunt patency studies useful in patients with shunted idiopathic intracranial hypertension in the emergency department? Clin Neurol Neurosurg. 2015;138:89–93. https://doi.org/10.1016/j.clineuro.2015.08.008.
Liu A, Elder BD, Sankey EW, Goodwin CR, Jusue-Torres I, Rigamonti D. The utility of computed tomography in shunted patients with idiopathic intracranial hypertension presenting to the emergency department. World Neurosurg. 2015;84(6):1852–6. https://doi.org/10.1016/j.wneu.2015.08.008.
Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol. 2011;32(8):1408–14. https://doi.org/10.3174/ajnr.A2575.
Radvany MG, Solomon D, Nijjar S, Subramanian PS, Miller NR, Rigamonti D, et al. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuroophthalmol. 2013;33(2):117–22. https://doi.org/10.1097/WNO.0b013e31827f18eb.
Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012;116(3):538–48. https://doi.org/10.3171/2011.10.JNS101410.
Ahmed RM, Zmudzki F, Parker GD, Owler BK, Halmagyi GM. Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting. AJNR Am J Neuroradiol. 2014;35(5):952–8. https://doi.org/10.3174/ajnr.A3806.
Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M, et al. Quality of life in idiopathic intracranial hypertension at diagnosis: IIH treatment trial results. Neurology. 2015;84(24):2449–56. https://doi.org/10.1212/WNL.0000000000001687.
Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ. Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015;16(1):521.
Ravid S, Shahar E, Schif A, Yehudian S. Visual outcome and recurrence rate in children with idiopathic intracranial hypertension. J Child Neurol. 2015;30(11):1448–52. https://doi.org/10.1177/0883073815569306.
Gospe SM 3rd, Bhatti MT, El-Dairi MA. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension. Br J Ophthalmol. 2016;100(4):505–9. https://doi.org/10.1136/bjophthalmol-2015-307043.
Agarwal A, Vibha D, Prasad K, Bhatia R, Singh MB, Garg A, et al. Predictors of poor visual outcome in patients with idiopathic intracranial hypertension (IIH): an ambispective cohort study. Clin Neurol Neurosurg. 2017;159:13–8. https://doi.org/10.1016/j.clineuro.2017.05.009.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Shawn C. Aylward and Amanda L. Way declare no conflict of interest.
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Additional information
This article is part of the Topical Collection on Childhood and Adolescent Headache
Rights and permissions
About this article
Cite this article
Aylward, S.C., Way, A.L. Pediatric Intracranial Hypertension: a Current Literature Review. Curr Pain Headache Rep 22, 14 (2018). https://doi.org/10.1007/s11916-018-0665-9
Published:
DOI: https://doi.org/10.1007/s11916-018-0665-9